Viability of MIN6 cell lines treated with various pharmacological reagents. by Barbara Pucelik (2988795)

Blocking CD88 decreased ANCA antigen translocation, ANCA-induced respiratory burst and degranulation in C5a-primed neutrophils. by Jian Hao (160736)

“…C and D: blocking CD88 decreased C5a-primed neutrophils for ANCA-induced respiratory burst. …”

Intracellular ROS decrease mediated by TAT-fused protein delivery. by Cecilia L. Balaban (4424212)

HvPIN1a localisation is influenced by BFA and its expression is decreased by cytokinin. by Gwendolyn K. Kirschner (5142644)

PDK1 inhibitor PF-5177624 decreased IGF-I induced AKT and p70S6K phosphorylation. by Sangita M. Baxi (123560)

Models of G48D, M78I, G125C, and A146V RAD52 point mutants. by Abdulaziz B. Hamid (13804692)

Variation of unconfined compressive strength under different (injection rates/ grouting rounds/ cementation concentrations): (a) Speed of 0.5 mL/min; (b) Speed of 3 mL/min;Speed of... by Xiaoyan Ding (291429)

Meta-analysis of AT (ml/kg/min) and morbidity. by Nabeela Arbee-Kalidas (17598969)

“…Using a previously defined cutoff value of > 15mL/kg/min for peak, showed evidence of decreased odds of mortality [OR: 0.55, 95% CI: 0.28–0.81] and but not decreased odds of postoperative morbidity [OR: 0.82, 95% CI: 0.64–1.00]. …”

Meta-analysis of peak (L/min) and morbidity. by Nabeela Arbee-Kalidas (17598969)

“…Using a previously defined cutoff value of > 15mL/kg/min for peak, showed evidence of decreased odds of mortality [OR: 0.55, 95% CI: 0.28–0.81] and but not decreased odds of postoperative morbidity [OR: 0.82, 95% CI: 0.64–1.00]. …”

Resveratrol decreased tumor latency in <i>Sirt1^Y/+</i> mice. by Katherine V. Clark-Knowles (368164)

Glu58 and Arg87 minimal distance decreases upon activation. by Maxime Louet (150102)

AEBS decreases Th17 cell numbers in CIA mice. by Hong Ki Min (823320)

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

Treatment with wt- or S360A-(A)PC decreases infarct area. by Karin C. A. A. Wildhagen (599651)

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

Compared to vorinostat, M344 decreases pancreatic cancer cell proliferation more effectively for a longer duration. by Shelby M. Knoche (13833807)

Additional behavioral patterns in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

Fig 5 - by Wenping Dong (3854437)

TIRF analyses of pericentrin-depleted MIN6 cells at non-stimulatory glucose concentration (2.5 mM) show increase in docked insulin granules and decrease at stimulatory glucose conc... by Agata Jurczyk (245201)

MCM-BP can decrease phosphorylation by DDK but is not a substrate. by Tin Nguyen (231591)